SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesmarket

FREN.DE (FREN.DE) News

Track canonical SquawkNews coverage tagged to FREN.DE, FREN.DE. This hub brings together deduplicated headlines about market instrument, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol FREN.DE Asset market Sector Markets 90 days 1 Updated Sep 19, 2026, 05:47 PM UTC Open live news feed
L Fresenius — controlled mAbxience teams with Sandoz on emicizumab biosimilar development, manufacturing Fresenius-controlled mAbxience signed a licensing, development, manufacturing, marketing deal with Sandoz for an emicizumab biosimilar candidate. mAbxience will develop and manufacture in GMP-certified plants in Spain, A NEWS | Sep 19, 2026, 05:47 PM UTC